RxDoctor Payments Data

Robert Bauer

Psychiatry · Florence, SCNPI 1508240250

Payments from drug & device makers

$2,604in general payments, 2019–2025

Across 132 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$658
  • Otsuka America Pharmaceutical, Inc.$496
  • Johnson & Johnson$376
  • E.r. Squibb & Sons, L.L.C.$302
  • Neurocrine Biosciences, Inc.$241
  • Alkermes, Inc.$119
  • plus $412 from 11 others

What the payments were for

  • Food & beverage$2,604100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,604 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate24$192,491
Invega SustennaPaliperidone Palmitate41$108,861
Austedo XrDeutetrabenazine14$82,138
AustedoDeutetrabenazine20$64,571
VraylarCariprazine Hcl35$50,307
RexultiBrexpiprazole24$47,513
CaplytaLumateperone Tosylate29$45,348
PerserisRisperidone12$23,073
SavellaMilnacipran Hcl23$13,152
Aripiprazole180$6,354
Quetiapine Fumarate270$3,447
Divalproex Sodium93$3,185
Bupropion XlBupropion Hcl196$2,926
Olanzapine175$2,767
Mirtazapine156$2,759

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$241$192,49124 claims
Johnson & JohnsonInvega Sustenna$376$108,86141 claims
AbbVieVraylar, Savella$658$63,46058 claims
Otsuka America Pharmaceutical, Inc.Rexulti$496$47,51324 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$32$45,34829 claims
Indivior Inc.Perseris$17$23,07312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →